// App-Quantinova.ai

: Effect of Switching from Well‐controlled Vitamin K Antagonists to a Direct Oral Anticoagulant for Atrial Fibrillation on Quality of Fife: Little to GAInN

Researchers

Presenter

  • J.H.A. van Miert

Principal Investigators

  • H.A.M. Kooistra

  • N.J.G.M. Veeger

  • A. Westerterp

  • M. Piersma

  • K. Meijer

Medical Centers

  • University of Groningen and University Medical Center Groningen, Groningen, Netherlands

  • Certe Thrombosis Service, Groningen, the Netherlands

  • University of Groningen and University Medical Center Groningen, Groningen, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

  • Venous thrombosis

Biomarkers

  • Transthyretin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved